DELCATH SYSTEMS, INC.·4

Jun 22, 4:14 PM ET

Muir Kevin 4

4 · DELCATH SYSTEMS, INC. · Filed Jun 22, 2023

Insider Transaction Report

Form 4
Period: 2023-06-12
Muir Kevin
GM INTERVENTIONAL ONCOLOGY
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-12+59,81359,813 total
    Exercise: $7.25Exp: 2033-06-12Common Stock (59,813 underlying)
Footnotes (1)
  • [F1]The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on July 12, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION